Interestingly, CD8+ CAR T cells co-expressing PD-1 with either LAG-3 or TIM-3 were associated with poor responses in CLL, whereas patients who had complete and durable remissions were infused with CAR T cells containing lower frequencies of these exhausted phenotypes. The gene discussed is PDCD1; the disease is B-cell chronic lymphocytic leukemia.